TEMSIROLIMUS for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 60 adverse event reports in the FDA FAERS database where TEMSIROLIMUS was used for Neoplasm malignant.
Most Reported Side Effects for TEMSIROLIMUS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 158 | 9.6% | 66 | 50 |
| Death | 136 | 8.3% | 135 | 14 |
| Stomatitis | 100 | 6.1% | 17 | 51 |
| Anaemia | 89 | 5.4% | 16 | 44 |
| Neoplasm progression | 84 | 5.1% | 33 | 24 |
| Vomiting | 81 | 4.9% | 13 | 52 |
| Diarrhoea | 79 | 4.8% | 9 | 51 |
| Febrile neutropenia | 78 | 4.7% | 1 | 66 |
| Pneumonia | 76 | 4.6% | 23 | 52 |
| Off label use | 75 | 4.6% | 15 | 12 |
| Fatigue | 74 | 4.5% | 15 | 25 |
| Pyrexia | 73 | 4.4% | 11 | 52 |
| Dehydration | 69 | 4.2% | 4 | 62 |
| Thrombocytopenia | 62 | 3.8% | 15 | 21 |
| Dyspnoea | 59 | 3.6% | 16 | 27 |
Other Indications for TEMSIROLIMUS
Renal cell carcinoma (213)
Metastatic renal cell carcinoma (131)
Embryonal rhabdomyosarcoma (121)
Product used for unknown indication (88)
Renal cancer (69)
Mantle cell lymphoma (65)
Rhabdomyosarcoma (51)
Alveolar rhabdomyosarcoma (38)
Metastatic malignant melanoma (35)
Renal cancer metastatic (29)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)